Simon Tarsh
Finanzdirektor/CFO bei RENOVARO INC.
Vermögen: - $ am 30.04.2024
Profil
Simon Tarsh is currently a Senior Managing Director-Finance Enterprise at Deloitte Consulting LP since 2007.
He is also an Independent Director at Onconetix, Inc. since 2022 and the Chief Financial Officer at Renovaro, Inc. since 2024.
Previously, he served as an Independent Director at Blue Water Biotech, Inc. Mr. Tarsh obtained his undergraduate degree from the University of Salford in 1981 and an MBA from Bayes Business School in 1988.
Bekannte Unternehmensbeteiligungen
| Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
|---|---|---|---|---|
ONCONETIX INC
-.--% | 05.04.2024 | 0 ( -.--% ) | - $ | 30.04.2024 |
RENOVARO INC.
-.--% | 11.03.2024 | 0 ( -.--% ) | - $ | 30.04.2024 |
Aktive Positionen von Simon Tarsh
| Unternehmen | Position | Beginn |
|---|---|---|
| ONCONETIX, INC. | Direktor/Vorstandsmitglied | 01.08.2022 |
| RENOVARO INC. | Finanzdirektor/CFO | 11.03.2024 |
Deloitte Consulting LP
 Deloitte Consulting LP Miscellaneous Commercial ServicesCommercial Services Deloitte Consulting LP provides accounting and auditing services. The private company is based in New York, NY. | Corporate Officer/Principal | 01.01.2007 |
Ehemalige bekannte Positionen von Simon Tarsh
| Unternehmen | Position | Ende |
|---|---|---|
Blue Water Biotech, Inc.
 Blue Water Biotech, Inc. Pharmaceuticals: MajorHealth Technology Blue Water Biotech, Inc. is a biotechnology company, which engages in the research and development of transformational vaccines to prevent infectious diseases worldwide. Its platform includes the BWV Norovirus (NoV) S&P Nanoparticle Versatile Vaccine. Bioengineering the shell (S) and protruding (P) domains of the norovirus capsid protein, polyvalent nanoparticles and polymers/oligomers provide a versatile vaccine platform with wide applications. The company was founded by Joseph Hernandez on October 26, 2018 and is headquartered in Cincinnati, OH. | Direktor/Vorstandsmitglied | - |
Ausbildung von Simon Tarsh
| University of Salford | Undergraduate Degree |
| Bayes Business School | Masters Business Admin |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Börsennotierte Unternehmen | 2 |
|---|---|
| ONCONETIX, INC. | Health Technology |
| RENOVARO INC. | Health Technology |
| Private Unternehmen | 2 |
|---|---|
Blue Water Biotech, Inc.
Blue Water Biotech, Inc. Pharmaceuticals: MajorHealth Technology Blue Water Biotech, Inc. is a biotechnology company, which engages in the research and development of transformational vaccines to prevent infectious diseases worldwide. Its platform includes the BWV Norovirus (NoV) S&P Nanoparticle Versatile Vaccine. Bioengineering the shell (S) and protruding (P) domains of the norovirus capsid protein, polyvalent nanoparticles and polymers/oligomers provide a versatile vaccine platform with wide applications. The company was founded by Joseph Hernandez on October 26, 2018 and is headquartered in Cincinnati, OH. | Health Technology |
Deloitte Consulting LP
Deloitte Consulting LP Miscellaneous Commercial ServicesCommercial Services Deloitte Consulting LP provides accounting and auditing services. The private company is based in New York, NY. | Commercial Services |
